Search research articles
Contact Us
Filters
Showing results (51-60 of 179) with videos related to
Page
of 18
Sort By:
Blood Advances
|
May 5, 2022
Treatment-free remission after ceasing venetoclax-based therapy in patients with acute myeloid leukemia
Chong Chyn Chua, Danielle Hammond, Andrew Kent, et al.
Nature Communications
|
September 14, 2018
Characterization and targeting of malignant stem cells in patients with advanced myelodysplastic syndromes
Brett M Stevens, Nabilah Khan, Angelo D'Alessandro, et al.
Haematologica
|
February 18, 2017
Changes in allele frequencies of <i>CSF3R</i> and <i>SETBP1</i> mutations and evidence of clonal evolution in a chronic neutrophilic leukemia patient treated with ruxolitinib
Zohra Nooruddin, Nicholas Miltgen, Qi Wei, et al.
Bone Marrow Transplantation
|
October 14, 2021
Venetoclax and azacitidine followed by allogeneic transplant results in excellent outcomes and may improve outcomes versus maintenance therapy among newly diagnosed AML patients older than 60
Daniel A Pollyea, Amanda Winters, Christine McMahon, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 24, 2018
Thiotepa-Based Intensified Reduced-Intensity Conditioning Adult Double-Unit Cord Blood Hematopoietic Stem Cell Transplantation Results in Decreased Relapse Rate and Improved Survival Compared with Transplantation Following Standard Reduced-Intensity Conditioning: A Retrospective Cohort Comparison
Prashant Sharma, Daniel A Pollyea, Clayton A Smith, et al.
Leukemia & Lymphoma
|
September 4, 2024
Response to intensive induction chemotherapy after failure of frontline azacitidine and venetoclax in acute myeloid leukemia
Kellen B Gil, Diana Abbott, Maria L Amaya, et al.
Molecular Cytogenetics
|
July 7, 2022
21q22 amplification detection in three patients with acute myeloid leukemia: cytogenomic profiling and literature review
Emily M Kudalkar, Changlee Pang, Mary M Haag, et al.
Haematologica
|
September 11, 2025
Impact of demographic factors on clinical outcomes of patients with acute myeloid leukemia
Cassandra Duarte, Diana Abbot, Grace Bosma, et al.
Cancer
|
October 26, 2025
County-level medical debt and treatment initiation among individuals newly diagnosed with cancer
Jingxuan Zhao, Marcelo Perraillon, Roxanne M Clark, et al.
Experimental Hematology
|
May 29, 2019
CD123 CAR T cells for the treatment of myelodysplastic syndrome
Brett M Stevens, Wei Zhang, Daniel A Pollyea, et al.
Page
of 18
Search research articles
Search
Showing results (51-60 of 179) with videos related to
Sort By:
Page
of 18
Blood Advances
|
May 5, 2022
Treatment-free remission after ceasing venetoclax-based therapy in patients with acute myeloid leukemia
Chong Chyn Chua, Danielle Hammond, Andrew Kent, et al.
Nature Communications
|
September 14, 2018
Characterization and targeting of malignant stem cells in patients with advanced myelodysplastic syndromes
Brett M Stevens, Nabilah Khan, Angelo D'Alessandro, et al.
Haematologica
|
February 18, 2017
Changes in allele frequencies of <i>CSF3R</i> and <i>SETBP1</i> mutations and evidence of clonal evolution in a chronic neutrophilic leukemia patient treated with ruxolitinib
Zohra Nooruddin, Nicholas Miltgen, Qi Wei, et al.
Bone Marrow Transplantation
|
October 14, 2021
Venetoclax and azacitidine followed by allogeneic transplant results in excellent outcomes and may improve outcomes versus maintenance therapy among newly diagnosed AML patients older than 60
Daniel A Pollyea, Amanda Winters, Christine McMahon, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 24, 2018
Thiotepa-Based Intensified Reduced-Intensity Conditioning Adult Double-Unit Cord Blood Hematopoietic Stem Cell Transplantation Results in Decreased Relapse Rate and Improved Survival Compared with Transplantation Following Standard Reduced-Intensity Conditioning: A Retrospective Cohort Comparison
Prashant Sharma, Daniel A Pollyea, Clayton A Smith, et al.
Leukemia & Lymphoma
|
September 4, 2024
Response to intensive induction chemotherapy after failure of frontline azacitidine and venetoclax in acute myeloid leukemia
Kellen B Gil, Diana Abbott, Maria L Amaya, et al.
Molecular Cytogenetics
|
July 7, 2022
21q22 amplification detection in three patients with acute myeloid leukemia: cytogenomic profiling and literature review
Emily M Kudalkar, Changlee Pang, Mary M Haag, et al.
Haematologica
|
September 11, 2025
Impact of demographic factors on clinical outcomes of patients with acute myeloid leukemia
Cassandra Duarte, Diana Abbot, Grace Bosma, et al.
Cancer
|
October 26, 2025
County-level medical debt and treatment initiation among individuals newly diagnosed with cancer
Jingxuan Zhao, Marcelo Perraillon, Roxanne M Clark, et al.
Experimental Hematology
|
May 29, 2019
CD123 CAR T cells for the treatment of myelodysplastic syndrome
Brett M Stevens, Wei Zhang, Daniel A Pollyea, et al.
Page
of 18